• Product Namevitamin B1 (thiamine hydrochloride)
  • CasNo. 67-03-8
  • MFC12H17ClN4OS.HCl
  • MW337.273
  • Purity
  • AppearanceWhite crystalline powder
  • Packing
  • Contact usInquiry

Product Details

CasNo: 67-03-8

MF: C12H17ClN4OS.HCl

Appearance: White crystalline powder

High-end vitamin B1 (thiamine hydrochloride) 67-03-8 top sale around the world

  • Molecular Formula:C12H17ClN4OS.HCl
  • Molecular Weight:337.273
  • Appearance/Colour:White crystalline powder 
  • Melting Point:250 °C (dec.)(lit.) 
  • Refractive Index:1.6000 (estimate) 
  • PKA:pKa 4.8 (Uncertain);9.0 (Uncertain) 
  • Flash Point:100oC 
  • PSA:104.15000 
  • Density:1.401 g/cm3 
  • LogP:-1.00510 
  • IDLH:1030 
  • IDLH:10493 
  • IDLH:3322 

Thiamine hydrochloride(Cas 67-03-8) Usage

Preparation

By linking the preformed thiazole and pyrimidine ring system.

Health Hazard

Diseases and disorders resulting from a deficiency of thiamine include beriberi, opisthotonos (in birds), polyneuritis, hyperesthesia, bradycardia, and edema. Rather than a specific disease, beriberi may be described as a clinical state resulting from a thiamine deficiency. In body cells, thiamine pyrophosphate is required for removing carbon dioxide from various substances, including pyruvic acid.

Biochem/physiol Actions

Thiamine is an essential coenzyme in carbohydrate metabolism. Deficiency of thiamine causes beriberi, a neurological and cardiovascular disease. Thiamine is administered in case of deficiency, either due to reduced intake or synthesis. Congenital defect in the thiamine transporter gene SLC19A2 causes thiamine-responsive megaloblastic anemia syndrome (TRMA). Thiamine mimics acetylcholine in brain and possible exerts a role in Alzheimer′s disease. Thiamine deficiency in ruminants causes polioencephalomalacia.

Safety Profile

Poison by intravenous and intraperitoneal routes. Mildly toxic by ingestion. The vitamin is destroyed by alkalies and alkaline drugs such as phenobarbital sodium and by oxidzing and reducing agents. When heated to decomposition it emits very toxic fumes of HCl, Cl-, SOx, and NOx.

Environmental Fate

Thiamine and its common phosphate analogs are readily soluble in water and ubiquitously utilized in nature.

Purification Methods

The hydrochloride crystallises from 95% EtOH (solubility is ca 1%). The monohydrate is dehydrated at 100o in vacuo over H2SO4, but is hygroscopic and picks up one molecule of H2O readily. It can be sterilised at 100o if the pH of the solution is below 5.5. The nitrate has m 196-200o(dec) and is more stable than the hydrochloride. The picrolonate crystallises from H2O and is dimorphic, m 164-165o and 228-229o(dec). [Todd & Bergel J Chem Soc 364, 367 1937, J Am Chem Soc 58 1063, 1504 1936, 59 526 1937, Beilstein 27 IV 1766.]

Definition

ChEBI: A hydrochloride obtained by combining thiamine chloride with one molar equivalent of hydrochloric acid.

General Description

Thiamine is a water-soluble vitamin of the B complex whose phosphate derivatives are involved in many cellular processes required for overall human health. Thiamine deficiency, often the result of impaired nutritional status associated with chronic diseases from alcoholism to HIV-AIDS, is monitored in patient whole blood samples by HPLC.

Who Evaluation

Evaluation year: 2002

InChI:InChI=1/2C12H17N4OS.4ClH/c2*1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;;;;/h2*5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);4*1H/q2*+1;;;;/p-4

67-03-8 Relevant articles

Possible impurities in 2-methyl-4-amino-5-chloromethylpyrimidine and the resulting quality of vitamin B1

Litvak

, p. 101 - 103 (1999)

-

Production of thiamine, riboflavin, folic acid, and biotin by Chlorella vulgaris and Chlorella pyrenoidosa.

Pratt,Johnson

, p. 871 - 874 (1965)

-

Synthetic process for chlorinated thiazole onium hydrochloride

-

Paragraph 0027; 0028; 0029; 0030; 0031; 0032, (2017/06/06)

The invention provides a synthetic proce...

Method for treating fibrotic diseases or other indications IC

-

, (2011/07/06)

Provided, among other things, is a metho...

Controlled release pharmaceutical preparation

-

, (2008/06/13)

A controlled release pharmaceutical prep...

67-03-8 Process route

(4-amino-2-methyl-pyrimidin-5-ylmethyl)-dicarbothioamidoic acid-(1-acetyl-3-hydroxy-propyl ester)
52164-53-1

(4-amino-2-methyl-pyrimidin-5-ylmethyl)-dicarbothioamidoic acid-(1-acetyl-3-hydroxy-propyl ester)

Thiamine hydrochloride
67-03-8,70732-86-4

Thiamine hydrochloride

Conditions
Conditions Yield
With hydrogenchloride; dihydrogen peroxide; In water; at -10 ℃; for 20h;
94.7%
5-hydroxyethyl-4-methylthiazole
137-00-8,8042-97-5

5-hydroxyethyl-4-methylthiazole

5-ethoxymethyl-2-methyl-pyrimidin-4-ylamine
73-66-5

5-ethoxymethyl-2-methyl-pyrimidin-4-ylamine

Thiamine hydrochloride
67-03-8,70732-86-4

Thiamine hydrochloride

Conditions
Conditions Yield
5-ethoxymethyl-2-methyl-pyrimidin-4-ylamine; With hydrogenchloride; In water; at 90 - 95 ℃; for 5h;
5-hydroxyethyl-4-methylthiazole; at 102 ℃; for 4h;
0.85 g

67-03-8 Upstream products

  • 31375-20-9
    31375-20-9

    4-Amino-2-methyl-5-thioformamidomethylpyrimidin

  • 13051-49-5
    13051-49-5

    5-Acetoxy-3-chloropentan-2-one

  • 31375-19-6
    31375-19-6

    3,4-Dihydro-7-methylpyrimido<4,5-d>pyrimidine

  • 55289-66-2
    55289-66-2

    3-Mercapto-4-oxopentyl Acetate

67-03-8 Downstream products

  • 59-58-5
    59-58-5

    thiamine propyl disulfide

  • 19498-76-1
    19498-76-1

    N-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-N-(4-hydroxy-1-methyl-2-phenyldisulfanyl-but-1-enyl)-formamide

  • 554-44-9
    554-44-9

    N-(2-allyldisulfanyl-4-hydroxy-1-methyl-but-1-en-t-yl)-N-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-formamide

  • 1476-77-3
    1476-77-3

    N-(4-amino-2-methyl-pyrimidin-5-ylmethyl)-N-(2-benzyldisulfanyl-4-hydroxy-1-methyl-but-1-enyl)-formamide

Relevant Products